THE ROLE OF WOMEN’S CONSULTATION CLINICS IN THE PREVENTION OF GYNECOLOGICAL DISEASES AMONG WOMEN OF REPRODUCTIVE AGE

Article Sidebar

PDF (Uzbek (latin))
Issue: Vol. 6 No. 2 : Eurasian Journal of Academic Research
Section: Articles
Published:
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Main Article Content

2-son Jamoat salomatligi va sog'liqni saqlashni boshqarish kafedrasi Toshkent davlat tibbiyot universiteti, O'zbekiston
info@in-academy.uz

Abstract:

Gynecological diseases remain a significant public health concern among women of reproductive age and contribute substantially to morbidity, reduced quality of life, and adverse reproductive outcomes. Preventive healthcare services play a crucial role in early detection, risk reduction, and timely management of gynecological conditions. Women’s consultation clinics represent a key component of primary healthcare systems, providing accessible reproductive health services, preventive examinations, health education, and counseling. This study aims to evaluate the role and effectiveness of women’s consultation clinics in the prevention of gynecological diseases among women of reproductive age. Particular attention is given to preventive strategies, including routine gynecological examinations, screening programs, health education, and early diagnosis.

Keywords:

Article Details

How to Cite:

Voitova, G. (2026). THE ROLE OF WOMEN’S CONSULTATION CLINICS IN THE PREVENTION OF GYNECOLOGICAL DISEASES AMONG WOMEN OF REPRODUCTIVE AGE. Eurasian Journal of Academic Research, 6(2), 84–90. Retrieved from https://in-academy.uz/index.php/ejar/article/view/74248

References:

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492

European Commission. (2015). European guidelines for quality assurance in cervical cancer screening (2nd ed.). Office for Official Publications of the European Union.

Kassebaum, N. J., Arora, M., Barber, R. M., Brown, J., Carter, A., Casey, D. C., … Vos, T. (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015. The Lancet, 388(10053), 1545–1602. https://doi.org/10.1016/S0140-6736(16)31678-6

Lönnberg, S., Anttila, A., Luostarinen, T., & Nieminen, P. (2013). Age-specific effectiveness of the Finnish cervical cancer screening programme. Cancer Epidemiology, Biomarkers & Prevention, 22(8), 1354–1361. https://doi.org/10.1158/1055-9965.EPI-13-0165

Moyer, V. A. (2012). Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 156(12), 880–891. https://doi.org/10.7326/0003-4819-156-12-201206190-00424

Oh, J. K., Weiderpass, E., & Franceschi, S. (2014). Epidemiology of vulvar and vaginal cancers. Best Practice & Research Clinical Obstetrics & Gynaecology, 28(1), 77–87. https://doi.org/10.1016/j.bpobgyn.2013.08.003

World Health Organization. (2016). WHO guidelines for the treatment of Chlamydia trachomatis. World Health Organization.

World Health Organization. (2022). Consolidated guideline on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care. World Health Organization.

World Health Organization. (2023). Global strategy for cervical cancer elimination. World Health Organization.